Susan Kaye Adams, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25065 Sanborn Rd, Calhan, CO 80808 Phone: 308-390-2594 |
Shine Therapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25065 Sanborn Rd, Calhan, CO 80808 Phone: 308-390-2594 |
News Archive
The Guardian reports that "60 finance and development ministers will gather in Washington on Friday at a high-level meeting on sanitation and water." According to the newspaper, "The Sanitation and Water for All meeting, convened by Anthony Lake, executive director of the U.N. children's fund UNICEF, follows an announcement in March by UNICEF and the World Health Organization that the world had met the millennium development goal (MDG) overall target for access to safe drinking water in 2010, but that 783 million people were still missing out."
Onset Dermatologics, a leader in developing and commercializing prescription products for improving skin health, today announced the launch of a 75mg strength of MINOCIN (minocycline hydrochloride) Pellet-Filled Capsules.
Takeda Pharmaceuticals International GmbH today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued positive opinions for updates to the Summary of Product Characteristics (SmPC) for Vipidia (alogliptin) and the fixed-dose combination (FDC) therapies Vipdomet (alogliptin and metformin) and Incresync (alogliptin and pioglitazone).
Gentium S.p.A. today reported financial results for the quarter ended September 30, 2010. The Company reports its financial condition and operating results using U.S. Generally Accepted Accounting Principles (GAAP). The Company's financial statements are prepared using the Euro as its functional currency.
Millions of individuals worldwide are exposed to shift work and numerous environmental conditions that disturb circadian clock function and disrupt normal circadian rhythms. Environmental conditions associated with disrupted circadian rhythms greatly increase the risk for development of type 2 diabetes and metabolic syndrome and also hinder the treatment and management of hyperglycemia in existing patients with diabetes.
› Verified 5 days ago